Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation
Saponin-based adjuvants are being explored as vaccine components as they induce high levels of antigen cross-presentation, but it is unknown how. Here the authors show that these adjuvants enhance cross-presentation by driving production of lipid bodies inside CD11b dendritic cells.
Guardado en:
Autores principales: | Martijn H. den Brok, Christian Büll, Melissa Wassink, Annemarie M. de Graaf, Jori A. Wagenaars, Marthe Minderman, Mayank Thakur, Sebastian Amigorena, Eric O. Rijke, Carla C. Schrier, Gosse J. Adema |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5b83830e5f2e45ffac906cc79476ab4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice.
por: Stefan Nierkens, et al.
Publicado: (2009) -
ISCOM-like Nanoparticles Formulated with <i>Quillaja brasiliensis</i> Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines
por: Mariana Rivera-Patron, et al.
Publicado: (2021) -
Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant
por: Zhao JH, et al.
Publicado: (2017) -
Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Sara Nava, et al.
Publicado: (2021) -
SAPONINS FROM CARINIANA RUBRA (LECYTHIDACEAE)
por: LIMA,EVANGELISTA, et al.
Publicado: (2002)